Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 4:32 pm Purchase | 2024-09-30 | 13G | Adagene Inc. ADAG | Huang James | 4,015,000 7.300% | 1,265,000 (+46.00%) | Filing History |
| 2024-10-29 4:05 pm Purchase | 2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,435,000 9.200% | 305,000 (+26.99%) | Filing History |
| 2024-06-11 4:10 pm Sale | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,130,000 8.400% | -1,565,000 (-58.07%) | Filing History |
| 2024-02-13 4:30 pm Sale | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Huang James | 0 0.000% | -176,667 (Position Closed) | Filing History |
| 2024-01-26 08:31 am Purchase | 2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,695,000 19.990% | 268,000 (+11.04%) | Filing History |
| 2024-01-19 08:37 am Purchase | 2024-01-18 | 13G | Adagene Inc. ADAG | Huang James | 2,750,000 5.000% | 2,750,000 (New Position) | Filing History |
| 2023-11-09 4:13 pm Purchase | 2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,427,000 18.000% | 677,000 (+38.69%) | Filing History |
| 2023-10-04 5:26 pm Purchase | 2023-10-02 | 13G | Connect Biopharma Holdings Limited CNTB | Huang James | 5,995,000 10.900% | 3,175,000 (+112.59%) | Filing History |
| 2023-06-22 9:15 pm Purchase | 2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,750,000 13.000% | 520,000 (+42.28%) | Filing History |
| 2023-05-17 07:30 am Purchase | 2023-05-17 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 1.500% | 4,200 (New Position) | Filing History |
| 2023-04-19 07:14 am Sale | 2023-04-18 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 0 0.000% | -4,200 (Position Closed) | Filing History |
| 2023-04-10 11:22 am Purchase | 2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,230,000 9.200% | 1,230,000 (New Position) | Filing History |
| 2023-03-10 12:15 pm Purchase | 2023-03-09 | 13G | Praxis Precision Medicines, Inc. PRAX | Huang James | 176,667 5.100% | 176,667 (New Position) | Filing History |
| 2023-02-23 4:31 pm Unchanged | 2023-02-22 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 8.700% | 0 (Unchanged) | Filing History |
| 2023-02-08 7:49 pm Purchase | 2023-01-30 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 8.600% | 4,200 (New Position) | Filing History |
| 2023-01-03 4:31 pm Purchase | 2022-12-22 | 13G | Connect Biopharma Holdings Limited CNTB | Huang James | 2,820,000 5.100% | 2,820,000 (New Position) | Filing History |